Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenax Therapeutics

7.34
-0.1300-1.74%
Post-market: 7.340.00000.00%18:07 EDT
Volume:29.56K
Turnover:217.83K
Market Cap:33.49M
PE:-7.82
High:7.54
Open:7.49
Low:7.15
Close:7.47
52wk High:8.24
52wk Low:4.32
Shares:4.56M
Float Shares:4.51M
Volume Ratio:0.37
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9392
EPS(LYR):-1.1526
ROE:-56.12%
ROA:-37.61%
PB:0.32
PE(LYR):-6.37

Loading ...

Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF

TIPRANKS
·
Oct 28

Tenax Therapeutics (TENX) Gets a Buy from Leerink Partners

TIPRANKS
·
Sep 18

Optimistic Buy Rating for Tenax Therapeutics Driven by Strong Patent Portfolio and Market Potential of Levosimendan

TIPRANKS
·
Sep 17

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

GlobeNewswire
·
Sep 16

BRIEF-Tenax Therapeutics Inc - Co And Orion Amend License Agreement - SEC Filing

Reuters
·
Sep 09

Tenax Therapeutics Expands Levosimendan License with Orion for Worldwide Oral Product Rights

Reuters
·
Sep 09

Tenax Therapeutics Inc - Under Amendment, Gains Exclusive Worldwide Rights for Levosimendan Products - SEC Filing

THOMSON REUTERS
·
Sep 09

Piper Sandler Initiates Tenax Therapeutics at Overweight With $20 Price Target

MT Newswires Live
·
Sep 08

Tenax Therapeutics Initiated at Overweight by Piper Sandler

Dow Jones
·
Sep 08

Tenax Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $20

THOMSON REUTERS
·
Sep 08

Press Release: IOCASTE VENTURES AND TENX PROTOCOLS ENTER INTO DEFINITIVE AGREEMENT

Dow Jones
·
Aug 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 18

Tenax Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 14

Tenax Therapeutics Reports Q2 2025 Net Loss of $10.9M, Up from $3.6M in Q2 2024; Increased R&D and G&A Expenses Cited

Reuters
·
Aug 14

Tenax Therapeutics Q2 EPS $(0.27) Misses $(0.24) Estimate

Benzinga
·
Aug 14

Tenax Therapeutics Q2 Net Income USD -10.847 Million

THOMSON REUTERS
·
Aug 14

Tenax Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
Aug 09

Tenax Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 18

Tenax Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Tenax Therapeutics Reports $10.4M Net Loss in Q1 2025, Up from $3.8M Loss in Q1 2024; R&D and G&A Expenses Surge

Reuters
·
May 15